Nasopharyngeal Neoplasms: all 242 studies
Page 3 of 3. Open to participants first (47), then studies with results posted, then the rest; newest registration first within each.
- Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal CancerStatus unknownNCT01074021Phase 3
- 124I-FIAU Imaging in EBV and KSHV Associated CancersCompletedNCT00982449Not applicable
- A Study of Lymphangiogenesis in Colorectal and Nasopharyngeal CancerStatus unknownNCT00943891
- Cluster Randomized Controlled Screening Trial for NPCStatus unknownNCT00941538Not applicable
- Coxib-inhibition of Duodenal Polyp Growth in FAPTerminatedNCT00844727Phase 2/3
- Induction Chemotherapy and Chemoradiotherapy in Nasopharyngeal CancersTerminatedNCT00828386Phase 3
- Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous PolyposisCompletedNCT00808743Phase 2/3
- Photon/Proton Radiation Therapy for Carcinoma of the NasopharynxTerminatedNCT00797290
- Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)CompletedNCT00747799Phase 2
- Administration of Epstein Barr Virus - Specific Cytotoxic T-Lymphocytes to Metastatic EBV-Positive Nasopharygneal CancerCompletedNCT00706316Phase 1
- Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based ChemotherapyCompletedNCT00630149Phase 2
- T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPCCompletedNCT00609219Phase 1
- Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal CancerStatus unknownNCT00577057Not applicable
- Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)Status unknownNCT00563927Not applicable
- Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0)TerminatedNCT00563862Not applicable
- Multimedia Intervention in Patients With Familial Adenomatous Polyposis (FAP)CompletedNCT00525655Not applicable
- Double-Blind Randomized Placebo-Controlled Trial on Clinical and Biological Effects of Oral Corticosteroids or Doxycyclin in Patients With Nasal PolyposisCompletedNCT00480298Phase 2
- A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer.CompletedNCT00439426Phase 2
- Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal CarcinomaCompletedNCT00436800Phase 2
- Taxotere + Cisplatin in Nasopharyngeal CarcinomaCompletedNCT00436293Phase 2
- Acupuncture for Prevention of Radiation-Induced XerostomiaCompletedNCT00430378Not applicable
- Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC FamiliesTerminatedNCT00393224
- A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following RadiotherapyCompletedNCT00370890Phase 3
- Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal CarcinomaStatus unknownNCT00363831Phase 2
- Family Study of Head and Neck Cancers in TaiwanCompletedNCT00342147
- Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous PolyposisStatus unknownNCT00319007Phase 2
- Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal CancerCompletedNCT00305734Phase 2
- Whole-Body 18F-FDG PET in Induction Chemotherapeutic Response for Advanced NPC PatientsStatus unknownNCT00304694
- Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis PatientsWithdrawnNCT00248053Phase 2
- Intensity Modulated Radiation Therapy for Head and Neck CancerCompletedNCT00188877Phase 2
- Swallowing Pattern of Patients With Nasopharyngeal Cancer Before and After Radiation Therapy: Longitudinal Study and Correction With Saliva AmountCompletedNCT00173836
- A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)TerminatedNCT00140894Phase 4
- Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) PatientsStatus unknownNCT00134758Phase 2/3
- Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland FunctionCompletedNCT00123864Phase 1/2
- Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasCompletedNCT00101270Phase 1
- Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal CancerStatus unknownNCT00093665Phase 2
- Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous TreatmentCompletedNCT00091182Phase 2
- EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)CompletedNCT00078546Phase 1
- Peptide Vaccine to Prevent Recurrence of Nasopharyngeal CancerCompletedNCT00078494Phase 1
- Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the NasopharynxTerminatedNCT00025298Phase 2
- Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal CancerCompletedNCT00003206Phase 2
- S9715, Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the NasopharynxWithdrawnNCT00002999Phase 2